Digestive Diseases and Sciences

, Volume 55, Issue 6, pp 1791–1793 | Cite as

Regression of B-Cell Lymphoma of the Liver with Hepatitis C Virus Infection After Treatment with Pegylated Interferon-α and Ribavirin

  • Yayoi Oda
  • Tadayuki Kou
  • Masaki Watanabe
  • Yojiro Sakuma
  • Nori Taguchi
  • Yoko Kato
  • Yasushi Kudo
  • Atsushi Yamauchi
  • Yasushi Sugiura
  • Shinya Ohashi
  • Masanori Asada
  • Toyokazu Fukunaga
  • Kiyotaka Kawaguchi
  • Hiroaki Ito
  • Takefumi Nakamura
  • Shujiro Yazumi
Case Report

Keywords

HCV Interferon Lymphoma Ribavirin 

References

  1. 1.
    Kuppers R. Mechanisms of B-cell lymphoma pathogenesis. Nat Rev Cancer. 2005;5:251–262.CrossRefPubMedGoogle Scholar
  2. 2.
    De Vita S, Sacco C, Sansonno D, et al. Characterization of overt B-cell lymphomas in patients with hepatitis C virus infection. Blood. 1997;90:776–782.PubMedGoogle Scholar
  3. 3.
    Zuckerman E, Zuckerman T, Levine AM, et al. Hepatitis C virus infection in patients with B-cell non-Hodgkin lymphoma. Ann Intern Med. 1997;127:423–428.PubMedGoogle Scholar
  4. 4.
    Mele A, Pulsoni A, Bianco E, et al. Hepatitis C virus and B-cell non-Hodgkin lymphomas: an Italian multicenter case-control study. Blood. 2003;102:996–999.CrossRefPubMedGoogle Scholar
  5. 5.
    Gisbert JP, Garcia-Buey L, Pajares JM, Moreno-Otero R. Prevalence of hepatitis C virus infection in B-cell non-Hodgkin’s lymphoma: systematic review and meta-analysis. Gastroenterology. 2003;125:1723–1732.CrossRefPubMedGoogle Scholar
  6. 6.
    Giordano TP, Henderson L, Landgren O, et al. Risk of non-Hodgkin lymphoma and lymphoproliferative precursor diseases in US veterans with hepatitis C virus. JAMA. 2007;297:2010–2017.CrossRefPubMedGoogle Scholar
  7. 7.
    Suarez F, Lortholary O, Hermine O, Lecuit M. Infection-associated lymphomas derived from marginal zone B cells: a model of antigen-driven lymphoproliferation. Blood. 2006;107:3034–3044.CrossRefPubMedGoogle Scholar
  8. 8.
    Wotherspoon AC, Doglioni C, Diss TC, et al. Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet. 1993;342:575–577.CrossRefPubMedGoogle Scholar
  9. 9.
    Weng WK, Levy S. Hepatitis C virus (HCV) and lymphomagenesis. Leuk Lymphoma. 2003;44:1113–1120.CrossRefPubMedGoogle Scholar
  10. 10.
    Nieters A, Kallinowski B, Brennan P, et al. Hepatitis C and risk of lymphoma: result of the European multicenter case-control study EPILYMPH. Gastroenterology. 2006;131:1879–1886.CrossRefPubMedGoogle Scholar
  11. 11.
    Viswanatha DS, Dogan A. Hepatitis C virus and lymphoma. J Clin Patho. 2007;60:1378–1383.CrossRefGoogle Scholar
  12. 12.
    Hermine O, Lefrere F, Bronowicki JP, et al. Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection. N Engl J Med. 2002;347:89–94.CrossRefPubMedGoogle Scholar
  13. 13.
    Vallisa D, Bernuzzi P, Arcaini L, et al. Role of anti-hepatitis C virus (HCV) treatment in HCV-related, low-grade, B-cell, non-Hodgkin’s lymphoma: a multicenter Italian experience. J Clin Oncol. 2005;23:468–473.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2009

Authors and Affiliations

  • Yayoi Oda
    • 1
  • Tadayuki Kou
    • 1
  • Masaki Watanabe
    • 1
  • Yojiro Sakuma
    • 1
  • Nori Taguchi
    • 1
  • Yoko Kato
    • 1
  • Yasushi Kudo
    • 1
  • Atsushi Yamauchi
    • 1
  • Yasushi Sugiura
    • 1
  • Shinya Ohashi
    • 1
  • Masanori Asada
    • 1
  • Toyokazu Fukunaga
    • 1
  • Kiyotaka Kawaguchi
    • 1
  • Hiroaki Ito
    • 1
  • Takefumi Nakamura
    • 2
  • Shujiro Yazumi
    • 1
  1. 1.Digestive Disease Center, The Tazuke Kofukai Medical Research InstituteKitano HospitalOsakaJapan
  2. 2.Department of GastroenterologyTenri HospitalNaraJapan

Personalised recommendations